1: Okyo Pharma and the roadmap to IND submission to the FDA for dry eye treatment in 2022
1 pistes • 0 écoutes • 0 favoris
1: Okyo Pharma and the roadmap to IND submission to the FDA for dry eye treatment in 2022
Betsnat Bt
0:007:57
Business & Finance
Épisodes
1
1: Okyo Pharma and the roadmap to IND submission to the FDA for dry eye treatment in 2022
Betsnat Bt